Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) saw a large increase in short interest in December. As of December 31st, there was short interest totalling 22,500 shares, an increase of 5,525.0% from the December 15th total of 400 shares. Based on an average trading volume of 85,500 shares, the short-interest ratio is presently 0.3 days.
Analyst Ratings Changes
Several analysts recently issued reports on LZAGY shares. The Goldman Sachs Group raised shares of Lonza Group to a “strong-buy” rating in a research note on Wednesday, October 9th. Redburn Atlantic raised shares of Lonza Group to a “strong-buy” rating in a research note on Wednesday, November 27th.
View Our Latest Stock Analysis on Lonza Group
Lonza Group Price Performance
Lonza Group Company Profile
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
See Also
- Five stocks we like better than Lonza Group
- 3 Best Fintech Stocks for a Portfolio Boost
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- How to Invest in Blue Chip Stocks
- Delta Can Fly to New Highs in 2025; Here’s Why
- The Significance of Brokerage Rankings in Stock Selection
- Snowflake Stock: Bullish Upgrades Demand Investors’ Attention
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.